Invesco
PBE icon

Invesco’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

Invesco’s Portfolio PBE Stock Details PBE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-7,000
Closed -$259K – 4221
2013
Q4 		$259K Hold
7,000
– – ﹤0.01% 3719
2013
Q3 		$245K Sell
7,000
-500
-7% -$16.6K ﹤0.01% 3690
2013
Q2 		$217K Buy
+7,500
New +$213K ﹤0.01% 3650

Other funds holding PBE

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
TAM
Trillium Asset Management Boston, Massachusetts $3.01B AUM 19.96% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
NCM
Niemann Capital Management Stateline, Nevada $788K AUM 23.27% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Invesco's PBE Position: Q1 2014 in Review

Invesco sold out of Invesco Biotechnology & Genome ETF (PBE) in Q1 2014, closing a stake of 7,000 shares — an estimated $259K sold.

Invesco first reported a position in PBE in Q2 2013 and held it in 3 quarters. The position peaked at $259K in Q4 2013. 73 funds tracked by Wall St. Rank hold PBE as of Q1 2014.

  • Invesco reported no remaining Invesco Biotechnology & Genome ETF position as of Q1 2014 after selling out during the quarter.
  • Invesco sold 7,000 Invesco Biotechnology & Genome ETF shares in Q1 2014, an estimated $259K.
  • Invesco first reported a position in Invesco Biotechnology & Genome ETF in Q2 2013 and held it in 3 quarters.
  • Invesco's Invesco Biotechnology & Genome ETF position peaked at $259K in Q4 2013.
  • 73 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q1 2014.

Based on Invesco's 13F filing for Q1 2014, filed 15 May 2014.